Index.php

Our attorneys have filed a mass tort lawsuit on behalf of patients who cannot take xarelto took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical firms, like the makers of Xarelto, have a duty to ensure that their drugs are reasonably secure for use - and failure to perform so could be grounds for compensation. Our lawyers are working hard to get these hurt by the drug the compensation they're entitled to.

Although bleeding is actually a common complication related with anticoagulants, it has been alleged that Xarelto is a lot more unsafe than classic blood thinners due to the fact no antidote exists to reverse its blood-thinning effects. This signifies that, inside the occasion of an emergency, sufferers may possibly be at threat for irreversible bleeding troubles, like life-threatening internal and gastrointestinal hemorrhaging.

If you or even a loved a single suffered a severe bleeding event after taking Xarelto, you might have legal recourse. For much more data, speak to us right now to have your case reviewed, free of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are searching for compensation from Bayer and Janssen for past and future healthcare bills, lost wages, pain and suffering and, in circumstances of death, funeral expenditures. Moreover, they are in search of punitive damages, which are normally awarded to punish the defendant and deter other businesses from acting similarly.
Why Are Lawsuits Becoming Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is harmful and defective. The plaintiffs claim that, unlike classic anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Since of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding inside the event of an emergency. Plaintiffs within the lawsuits allege severe and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a safe anticoagulant option.
Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to significant bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing unsafe clotting.

Visit this page for much more info on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.